International Patent: IMPROVED INHIBITORS OF INSULIN-LIKE GROWTH FACTOR 2 MRNA BINDING PROTEINS

GENEVA, Aug. 31 -- MARTIN-LUTHER-UNIVERSITÄT HALLE-WITTENBERG, KÖRPERSCHAFT DES ÖFFENTLICHEN RECHTS filed a patent application (EP2026/054409) for “IMPROVED INHIBITORS OF INSULIN-LIKE GROWTH FACTOR 2 MRNA BINDING PROTEINS”. With publication no. WO/2026/175903, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 409/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....